Moneycontrol PRO
you are here: HomeNewsIndia

Coronavirus update: Spike in fresh COVID-19 cases, India records 68,020 new infections

Registering a steady increase for the 19th day in a row, the active cases have increased to 5,21,808, which comprise 4.33 percent of the total infections, while the recovery rate has further dropped to 94.32 percent, the data stated.

March 29, 2021 / 10:57 AM IST
Representative image (Source: Reuters)

Representative image (Source: Reuters)

India saw 68,020 new coronavirus cases in a span of 24 hours, the highest single-day rise so far this year, taking the country's COVID-19 tally to above 1.20 crore, according to Union Health Ministry data updated on Monday.

Registering a steady increase for the 19th day in a row, the active cases have increased to 5,21,808, which comprise 4.33 percent of the total infections, while the recovery rate has further dropped to 94.32 percent, the data stated.

A total of 68,020 new cases were reported in a day, the highest recorded since October 11 last year, taking the country's tally of cases to 1,20,39,644, while the death toll increased to 1,61,843 with 291 fatalities, the data updated at 8 am showed.

As many as 74,383 new cases were recorded in a span of 24 hours on October 11.

The active caseload was at its lowest at 1,35,926 on February 12 comprising 1.25 percent of the total infections.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The number of people who have recuperated from the disease surged to 1,13,55,993, while the case fatality rate has further has dropped to 1.34 percent, the data stated.

India's COVID-19 tally had crossed 20 lakh mark on August 7 last year, 30 lakh on August 23, 40 lakh on September 5 and 50 lakh on September 16.

It went past 60 lakh on September 28, 70 lakh on October 11, crossed 80 lakh on October 29, 90 lakh on November 20 and surpassed the one-crore mark on December 19 last year.

According to the Indian Council for Medical Research, 24,18,64,161 samples have been tested up to March 28 with 9,13,319 samples being tested on Saturday.

The 291 new fatalities include 108 from Maharashtra, 69 from Punjab, 15 from Chhattisgarh, 12 each from Kerala and Karnataka, and 11 each from Madhya Pradesh and Tamil Nadu.

A total of 1,61,843 deaths have been reported so far in the country, including 54,181 from Maharashtra, 12,670 from Tamil Nadu, 12,504 from Karnataka, 11,006 from Delhi, 10,324 from West Bengal, 8,786 from Uttar Pradesh, 7,205 from Andhra Pradesh and 6,690 from Punjab.

The health ministry stressed that more than 70 percent of the deaths occurred due to comorbidities.

"Our figures are being reconciled with the Indian Council of Medical Research," the ministry said on its website, adding that state-wise distribution of figures is subject to further verification and reconciliation.

PTI
first published: Mar 29, 2021 10:44 am